Sanofi SA (NASDAQ:SNY)
| 46.22 BATS BZX Real-Time Price As of 3:05pm ET |  +0.15 / +0.33%Today’s Change | 42.63 Today|||52-Week Range 57.82 | -4.56% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 38.1B | 37.3B | 39.5B | 40.7B | |
| Cost of Goods Sold | 10.1B | 10.5B | 11.8B | 12.1B | ||
| Depreciation And Amortization | 4.4B | 3.3B | 3.6B | 4.1B | ||
| Operating Expenses | Gross Income | 23.6B | 23.5B | 24.2B | 24.5B | |
| General Expenses | 15.9B | 16.1B | 17.4B | 18.5B | ||
| Other Operating Expenses | 0.00 | 0.00 | -10.2M | -3.5M | ||
| Research And Development | 5.6B | 5.7B | 6.1B | 6.9B | ||
| Total Operating Expenses | 30.4B | 29.9B | 32.8B | 34.7B | ||
| Non-Operating Expenses | Operating Income | 7.7B | 7.4B | 6.8B | 6.0B | |
| Extraordinary Credit | 152.3M | 94.9M | -- | 286.7M | ||
| Extraordinary Charge | -1.8B | -1.9B | -1.4B | -2.9B | ||
| Interest Expense On Debt | 475.7M | 437.1M | 412.8M | 580.4M | ||
| Equity In Earnings | -24.3M | 147.9M | 117.3M | 588.7M | ||
| Other Expenses | 112.6M | 968.0M | 1.1B | 2.3B | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 5.8B | 6.3B | 6.2B | 5.2B | |
| Income Taxes | -782.5M | -1.5B | -1.9B | -567.5M | ||
| Minority Interest | -111.5M | -100.4M | -136.5M | -122.7M | ||
| Discontinued Operations | -136.9M | 346.6M | 0.00 | 0.00 | ||
| Extraordinary Items | 0.00 | 0.00 | 5.2B | -15.3M | ||
| Net Income | 4.7B | 5.2B | 4.3B | 5.1B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.6B | 2.6B | 2.5B | 2.5B | |
| Shares To Calculate EPS Diluted | 2.6B | 2.6B | 2.5B | 2.5B | ||
| Earnings Per Share | EPS | $1.81 | $2.02 | $1.70 | $2.04 | |
| EPS Diluted | $1.79 | $2.00 | $1.69 | $2.03 | ||
